Objective: To evaluate the effect of maternal glycemic levels on computeriz
ed cardiotocography (cCTG) parameters respect to a matched control group an
d to assess how single parameters may vary with changing maternal glycemia.
Methods: cCTG recordings of nineteen euglycemic diabetic patients with bioc
hemically diagnosed diabetes (according to National Diabetes Data Group) an
d the same number of physiological pregnancies matched for maternal age, ge
nder and gestational age; were recruited from January 1999 to May 2000. Car
diotocograms were recorded by means of an Oxford Sonicaid System 8002 compu
terized fetal heart rate (FHR) equipment. We considered only FHR tracings g
reater than or equal to 40 min with plasmatic glycemia evaluation at the mi
ddle of FHR recording.
Results: We observed a significant difference in maternal plasmatic glycemi
c levels between diabetic and control group during cCTG analysis (p <0.001)
. There were no significant differences between cases and controls for all
cCTG parameters tested (FHR, LTV, STV, Acc10, Acc15, HV msec, LV msec and F
M/h). Correlating values of plasmatic glycemia with cCTG parameters in case
s and controls with the aim to evaluate the effect of maternal glycemia on
FHR trace parameters, we observed: in the control group a negative correlat
ion between Acc10 (accelerations > 10 bpm) and Acc15 (accelerations > 15 bp
m) and glycemic levels (r= -0.51, P <0.019 and r = -0.56, p <0.009), while
in the euglycemic diabetic group a negative correlation between episodes HV
msec and glycemic levels was found (r = -0.52, p <0.01).
Comment: We have observed that in third trimester euglycemic diabetic pregn
ancies, FHR parameters evaluated by means of a computerized system seem not
to be different from those of a control group. In euglycemic diabetic preg
nancies, to increased glycemic levels correspond less episodes of HV msec.
In normal pregnancies, to increased glycemic levels correspond less number
of Acc 10 and Acc 15.